Introduction: Glomerular diseases are a frequent etiology of chronic kidney disease, especially in the developing countries. Objective: To determine the profile of such glomerulopathies in a public hospital located in the city of Brasilia, Federal District. Methods: 121 renal biopsies in different patients were performed by the Renal Division of Hospital Regional da Asa Norte (HRAN) between August 2005 and May 2009. Eight renal biopsies in renal-transplant patients were excluded and the medical records of 113 remaining patients were analyzed. Analyzed data: sex, age, laboratory exams, glomerular syndrome, clinical diagnosis, degree of interstitial fibrosis, immunosuppressants use, need for dialysis and clinical outcome. Results: The age average was 34.9 ± 16.2 years-old, a predominance of male patients (51.3%). Major glomerular syndromes were: nephrotic syndrome (41.6%) and the rapidly-progressive glomerulonephritis (35.4%). Among primary glomerulopathies focal glomerulosclerosis (26.8%) followed by IgA nephropathy (25%) were predominant; and among the most prevalent secondary glomerulopathies we had lupus nephritis (50%) and diffuse exudative proliferative glomerulonephritis (34.2%).The majority of the patients used immunosuppressants (68.1%) and almost one third of them (29.2%) needed dialysis during their hospitalization. Progressed to chronic dialysis therapy 13.3% of the patients and 10.6% died. Conclusion: This study may contribute to better epidemiological understanding of glomerular diseases in the Federal District, guiding the adoption of public policies aiming the quick clinical treatment of such diseases. Keywords: nephropathy, nephritis, glomerulonephritis, nephrotic syndrome, lupus syndrome, focal segmental glomerulosclerosis, IgA nephropathy, chronic kidney disease [J Bras Nefrol 2010;32(3):248-255]©Elsevier Editora Ltda. Profile of glomerular diseases in a public hospital of Federal District, Brazil IntroductIonChronic kidney disease is currently understood as a public health problem, because of its increasing prevalence, high morbidity and mortality, and high costs for maintaining patients with chronic kidney disease (CKD) stage 5 in different modalities of renal replacement therapy (RRT) (hemodialysis, peritoneal dialysis, and kidney transplantation).1-3 Currently, over one million people worldwide are estimated to be on any form of chronic dialysis therapy, and Latin America accounts for almost one quarter of such patients. [4][5][6] The cost of that treatment is high: Brazilian data have shown that more than 10% of the budget of the Health Ministry is destined to maintain RRT programs, while North-American data point to a cost of 29 billion dollars per year to treat patients that need RRT. 7,8 In Brazil, as in several other countries, glomerular diseases are a frequent etiology of chronic kidney failure, 9,10 and kidney biopsy plays a fundamental role in the correct histopathological and etiological diagnosis and even in the prognosis of such cases. 11,12Glomerular diseases often have ...
Background: Few publications have evaluated temporal trends and outcomes of percutaneous coronary intervention in diabetic patients in the contemporary era. Our objective was to verify characteristics, procedural results and mortality of percutaneous coronary intervention in diabetic subjects in Brazil in the last 10 years. Methods: We analyzed the percutaneous coronary interventions registered in the Brazilian National Registry of Cardiovascular Interventions (CENIC) of
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.